InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Patel Ronil A.. Officer active across 1 company, notably Ocuphire Pharma, Inc.. Aggregated, 3 disclosures have been recorded. History available since 24 April 2023. The latest transaction was disclosed on 10 January 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations